Pfizer Inc. (PFE) Statement On Today’s Joint Meeting Of FDA Advisory Committees
2/12/2014 9:02:56 AM
NEW YORK--(BUSINESS WIRE)--Pfizer agrees with the recommendation of the joint meeting of the FDA Arthritis Advisory Committee and Drug Safety and Risk Management Advisory Committee that the available data do not support a conclusion that naproxen has a lower risk of cardiovascular thrombotic events as compared to other non-steroidal anti-inflammatory drugs (NSAIDs).
Help employers find you! Check out all the jobs and post your resume.
comments powered by